AMT-101

Home
Ligands
AMT-101

GtoPdb Ligand ID: 11645

Compound class: Peptide or derivative

Comment: AMT-101 is an orally deliverable IL-10-cholix fusion protein [1]. It combines the anti-inflammatory IL-10 with a nontoxic fragment of the cholix exotoxin from Vibrio cholerae. The exotoxin fragment facilitates delivery of the fusion protein selectively to the intestinal epithelium via transcytosis through intestinal enterocytes into the lamina propria, where it is intended to treat intestinal inflammatory diseases. IL-10 treatment is associated with dose limiting systemic toxicities including anemia and thrombocytopenia. AMT-101 was designed to overcome this limitation by restricting its IL-10 activity to within the GI tract.

Summary
Biological activity
Clinical data
References
Immunopharmacology

Immunopharmacology Comments
AMT-101 produces IL-10-mediated anti-inflammatory effects in in vivo models of intestinal inflammation [1]. It is a clinical candidate for diseases including ulcerative colitis and Crohn's disease.

Immunopharmacology Comments

AMT-101 produces IL-10-mediated anti-inflammatory effects in in vivo models of intestinal inflammation [1]. It is a clinical candidate for diseases including ulcerative colitis and Crohn's disease.